Cite Filings / RNAC / 0001950047-24-008888
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Cartesian Therapeutics, Inc. · Filed 2024-11-20 · Acc 0001950047-24-008888

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-11-21 144 Sale of Securities
  • 2024-11-21 4 Chief Technology Officer sold 38,689 shares at an average $16.78 ($649,030)
  • 2024-11-21 4 Director gave 28,821 shares (gift)
  • 2024-11-21 4 Chief Scientific Officer acquired 14,000 shares (option exercise)
  • 2024-11-20 144 Sale of Securities
  • 2024-11-19 144 Sale of Securities
  • 2024-11-18 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…